Rigel Pharmaceuticals RIGL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's total liabilities?
- Rigel Pharmaceuticals (RIGL) reported total liabilities of $104.71M in Q1 2026.
- How has Rigel Pharmaceuticals's total liabilities changed year-over-year?
- Rigel Pharmaceuticals's total liabilities decreased by 33.5% year-over-year, from $157.41M to $104.71M.
- What is the long-term trend for Rigel Pharmaceuticals's total liabilities?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's total liabilities has grown at a -2.8% compound annual growth rate (CAGR), from $136.95M to $122.11M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.